Headway has expanded its EHR system to include an AI-assisted notes feature and an integrated telehealth capability. The post Headway Launches Enhanced EHR Platform for Mental Health Providers appeared first on MedCity News.
The clinical decision support market is evolving quickly. With heavy investor backing and competing strategies around specialization, data depth and distribution, the coming years will determine which companies emerge as lasting leaders at the point of care. The post Inside the Clinical Decision Support Market: The Race to Make AI Work at the Point of…
LB Pharmaceuticals found enough investor interest to boost the size of its IPO, which will finance clinical trials in schizophrenia and bipolar depression. The biotech has modified an old Sanofi drug with changes intended to reduce side effects and allow less frequent dosing. The post LB Pharma Pushes the Biotech IPO Window Open, Bagging $285M…
The real story isn’t about denial rates or stakeholders acting as villains. It’s about a healthcare system that forces intelligent, well-intentioned professionals to make critical decisions in information silos. The post Healthcare’s Data Orchestra: Why Rising Drug Denials Signal a Need for Better Coordination appeared first on MedCity News.
The latest episode of the Debunked podcast explored an ongoing debate questioning the role of payers in healthcare transactions. It also highlighted turmoil at the CDC.. The post Debunked Episode 19: Turmoil at the CDC, Epic’s AI Strategy appeared first on MedCity News.
Early diagnostics for acute intoxication in the emergency department are about more than just identifying the cause of an overdose. They can enable timely intervention, reduce the risk of fatal outcomes, and open the door to substance use disorder treatment and recovery The post Racing the Clock: The Life-or-Death Power of Early Drugs-of-Abuse Diagnostics in…
In a crowded healthcare AI market, the winners will be those that control key leverage points — where data is created, workflows are streamlined and value is delivered across stakeholders. This will differentiate winning AI startups from incumbents and copycat competitors, said Morgan Cheatham, head of healthcare and life sciences at Breyer Capital. The post…
Many employers are struggling to access their medical claims data from vendors. However, those who do have access are more likely to implement strategies to combat healthcare costs. The post A Third of Employers Can’t Access Medical Claims Data from Vendors, Survey Finds appeared first on MedCity News.
A Johnson & Johnson cancer treatment that can spare certain bladder cancer patients from the radical step of surgical removal of the organ now has FDA approval. J&J’s drug/device combination product, Inlexzo, came from its 2019 acquisition of Taris Biomedical. The post FDA Nod for J&J’s Drug/Device Treatment Gives Bladder Cancer Patients Another Option appeared…
Now is a good time for health systems to step back and ask some foundational questions instead of rushing into their next AI purchase. The post The Hidden Cost of Healthcare AI: Why Premium Prices Don’t Equal Premium Results appeared first on MedCity News.